Logo
x

Search

Subscribe Now

Chiesi

Chiesi Receives the US FDA's Approval for Filsuvez as a Treatment for Epidermolysis Bullosa (EB)

Chiesi Receives the US FDA's Approval for Filsuvez as a Treatment for Epidermolysis Bullosa (EB)

  • December 19, 2023
Chiesi’s Elfabrio (pegunigalsidase alfa) Receives NICE Recommendation for Fabry Disease

Chiesi’s Elfabrio (pegunigalsidase alfa) Receives NICE Recommendation for Fabry Disease

  • September 5, 2023
PharmaShots' Key Highlights of First Quarter 2023

PharmaShots' Key Highlights of First Quarter 2023

  • April 3, 2023
Chiesi to Acquire Amryt Pharma for ~$1.48B

Chiesi to Acquire Amryt Pharma for ~$1.48B

  • January 9, 2023
PharmaShots Weekly Snapshot (Nov 30 - Dec 04, 2020)

PharmaShots Weekly Snapshot (Nov 30 - Dec 04, 2020)

  • December 4, 2020
PharmaShots Weekly Snapshot (November 16-20, 2020)

PharmaShots Weekly Snapshot (November 16-20, 2020)

  • November 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.